S

Sanofi

Global pharma company; vaccines and R&D

Business Relationship Manager

Full-TimeUpdated on 10/23/2026Deadline 11/13/26
No salary listed
Mid
Petaling Jaya, Selangor, Malaysia
In PersonThe description lists KL (Kuala Lumpur), Malaysia as the role location; ATS workplace scope is Petaling Jaya, Malaysia.
Sales & Account ManagementField Sales

About the job

Requirements
  • Engagement communication skills, including storytelling and presentation skills.
  • Relationship-building, listening, and networking skills.
  • Ability to deliver digital presentations using appropriate software and hardware.
  • Experience facilitating virtual meetings and fully utilizing virtual meeting tool features.
  • Training in digital channels.
  • Ability to understand customer needs and the customer journey.
  • Customer profiling and segmentation skills.
  • Business intelligence skills.
  • Data-driven decision-making skills.
  • Ability to understand and interpret data for decision-making.
  • Analytical mindset and ability to use data to improve the customer journey.
  • Strategic thinking.
  • Ability to explore how digital tools can positively affect customers.
  • Probing and iterative working method.
  • Ability to handle objections.
  • Cultural sensitivity.
  • Ability to embrace innovation and change.
  • Ability to comply with ethical codes, standard operating procedures, pharmacovigilance, quality, health, safety and environment protocols, and reporting obligations.
  • Ability to formulate sales action plans, prepare accurate forecasts, and implement plans to meet qualitative and quantitative cycle and annual sales targets.
  • Ability to promote assigned franchises in line with strategy and corporate direction.
  • Ability to execute sales expectations and business operations in compliance with standard operating procedures and ethical codes.
  • Ability to manage promotional budgets and direct funds to targeted customers.
  • Ability to use appropriate channels for accounts and deliver key messages through digital channels, including social media, web forums, webinars, and GPP.
  • Ability to identify, prospect, and qualify potential new customers.
  • Ability to create detailed prospecting plans, set key performance indicators, and monitor progress.
  • Ability to analyze business opportunities and strategies beyond the existing customer base.
  • Ability to cross-sell products and expand brand usage.
  • Ability to identify unsafe conditions or behaviors, notify the Manager of serious incidents, and complete and forward incident/injury reports to Human Resources within 48 hours when necessary.
Responsibilities
  • Engage with customers to promote product features and benefits based on approved indications.
  • Achieve territory sales and milestone objectives within the assigned territory and portfolio.
  • Contribute to defining and deploying the digital roadmap for Malaysia.
  • Shape the market and customer preferences for digital interaction and channel utilization.
  • Maintain in-depth knowledge of Sanofi Pasteur products and the customer journey, and stay informed about product information and medical and scientific updates related to the brand.
  • Deliver key messages and promote products through a wide range of digital channels.
  • Provide support and identify opportunities to deliver tailored solutions to customer needs.
  • Cultivate and maintain customer relationships to develop Sanofi’s credibility and advocacy for the company.
  • Identify attributes and customer-profile information relevant to territory growth.
  • Understand territory geography, business potential, relevant customer segments, channel preferences, and content preferences.
  • Create a network among stakeholders, including front-line staff, decision-makers, and gatekeepers.
  • Gather competitor information and market intelligence.
  • Update customer, call-detail, and market-insight information in customer relationship management systems daily.
  • Prepare pre-call plans, itineraries, and routing plans to achieve call targets, appointments, and in-service activities.
  • Analyze and present sales and customer data regularly to internal stakeholders, including managers and team members.
  • Implement marketing plans and promotional activities.
  • Build coordinated working relationships with internal and external stakeholders.
  • Maximize territory segments and channels to generate growth.
  • Adapt to changes in channel engagement and adopt digital tools.
  • Use new channels for promotional activity to reach and engage target customers beyond traditional methods, matching product messages to suitable digital channels.
  • Share best practices and growth and expansion opportunities.
  • Comply with assigned health, safety, and environment roles and responsibilities under existing policy.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...